Live Breaking News & Updates on Achieved clinical remission
Stay updated with breaking news from Achieved clinical remission. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
During the long-term extension of the GALAXI trial, 54.1% of participants treated with guselkumab achieved clinical remission and 34.7% achieved endoscopic response. ....
New data show proportions of patients treated with TREMFYA who achieved clinical-biomarker response ranged from 47.5-66.7 percent across dose grou. ....